Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Columnists

About Fabian Lorenz

Fabian Lorenz
Fabian Lorenz, Apaton
Fabian is a savvy investor with a degree in business administration and 20+ years in small/micro caps trading.

Fabian Lorenz's Most Recent Articles

Is China getting serious? Rheinmetall and Almonty Industries profit

It is well known that China is massively increasing its gold reserves. But why is it buying up...

Fabian Lorenz | 7 days ago

BASF and Cardiol Therapeutics recommended buys; TUI rides momentum

BASF (OTCQX:BASFY), Cardiol Therapeutics (TSX:CRDL) and TUI Group (OTCPK:TUIFF) deserve a closer...

Fabian Lorenz | April 10, 2024

Take a closer look at HelloFresh, Bayer and Altech Advanced Materials

Apaton Finance examines recent performance of three German companies: Altech Advanced Materials...

Fabian Lorenz | April 5, 2024